Skip to main content
Equibles

Dennis Sting

Analyst

Jefferies

Equibles does not estimate personal net worth.

About Dennis Sting

Dennis Sting is recorded as Analyst at Jefferies. Dennis Sting has spoken on 1 earnings call and 2 other investor events across 3 companies, most recently for Tarsus Pharmaceuticals, Inc. on November 3, 2026. Those appearances were for Tarsus Pharmaceuticals, Inc. (TARS), Collegium Pharmaceutical, Inc (COLL) and Ani Pharmaceuticals Inc (ANIP). The companies whose calls Dennis Sting spoke on are classified in the Healthcare sector.

Dennis Sting on recent calls

“So, first, I mean, when I think about all the positive signs you guys are seeing and compare that with consensus, which is 900 next year, but then 1.1 in 28 and then 1.25 in 29, eventually 2 billion all the way out in 2035, growth really needs to slow down significantly, which means to me there's either incremental…”
Analyst — Jefferies, Tarsus to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026 ·
“Well, welcome to the Jeffrey Self-Care Conference. My name is Dennis Sting. It's Midcap Biotech and Spec Pharma Analyst here. I have the great pleasure of having Collegian Pharmaceuticals here, CEO Vikram Karnani, as well as CFO Colleen Tupper.”
Analyst — Jefferies, 2026 Jefferies Global Healthcare Conference ·
“I have the wonderful pleasure of hosting ANI Pharmaceuticals. We have the CEO, Nikhil Lawani, here with us, as well as CFO, Stephen Carey. So welcome, guys.”
Analyst — Jefferies, 2026 Jefferies Global Healthcare Conference ·

Affiliation history

  • Jefferies

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity